{"paper_id":"2b4cd0a7-3984-49f6-99ba-52c16ed4e5b1","body_text":"References\nLu H, Li S, Wu Q (2018) Retinoic acid regulates endometriotic stromal cell growth through upregulation of Beclin1. Arch Gynecol Obstet 297(1):93–99. https://doi.org/10.1007/s00404-017-4549-8\nTaylor RN, Kane MA, Sidell N (2015) Pathogenesis of endometriosis: roles of retinoids and inflammatory pathways. Semin Reprod Med 33(4):246–256. https://doi.org/10.1055/s-0035-1554920\nHatice O, Abdullah B, Gökhan A, Remzi A, Ozlem Bozoklu A, Mehmet Ilkay K (2012) The efficacy of bevacizumab, sorafenib, and retinoic acid on rat endometriosis model. Reprod Sci 20(1):26–32. https://doi.org/10.1177/1933719112452941\nWieser F, Wu J, Shen Z, Taylor RN, Sidell N (2012) Retinoic acid suppresses growth of lesions, inhibits peritoneal cytokine secretion, and promotes macrophage differentiation in an immunocompetent mouse model of endometriosis. Fertil Steril 97(6):1430–1437. https://doi.org/10.1016/j.fertnstert.2012.03.004\nVercellini P, Vigano P, Somigliana E, Fedele L (2014) Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol 10(5):261–275. https://doi.org/10.1038/nrendo.2013.255\nYamagata Y, Takaki E, Shinagawa M, Okada M, Jozaki K, Lee L, Sato S, Maekawa R, Taketani T, Asada H, Tamura H, Nakai A, Sugino N (2015) Retinoic acid has the potential to suppress endometriosis development. J Ovarian Res 8:49. https://doi.org/10.1186/s13048-015-0179-6\nTafi E, Leone Roberti Maggiore U, Alessandri F, Bogliolo S, Gardella B, Vellone VG, Grillo F, Mastracci L, Ferrero S (2015) Advances in pharmacotherapy for treating endometriosis. Expert Opin Pharmacother 16(16):2465–2483. https://doi.org/10.1517/14656566.2015.1085510\nAuthor information\nAuthors and Affiliations\nContributions\nFB: Project development, data collection, manuscript writing. SF: Manuscript writing/editing.\nCorresponding author\nEthics declarations\nFunding\nThis paper is not funded.\nConflict of interest\nFabio Barra declares that he has no conflict of interest. Simone Ferrero declares that he has no conflict of interest.\nEthical approval\nThis article does not contain any studies with human participants or animals performed by any of the authors.\nRights and permissions\nAbout this article\nCite this article\nBarra, F., Ferrero, S. The use of retinoic acid for the treatment of endometriosis. Arch Gynecol Obstet 298, 231–232 (2018). https://doi.org/10.1007/s00404-018-4774-9\nReceived:\nAccepted:\nPublished:\nVersion of record:\nIssue date:\nDOI: https://doi.org/10.1007/s00404-018-4774-9","source_license":"CC0","license_restricted":false}